Cardiac troponin T as a serum biomarker of respiratory impairment in amyotrophic lateral sclerosis
Annals of Clinical and Translational Neurology · 2024
DOI: 10.1002/acn3.52126 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Annals of Clinical and Translational Neurology, 2024. Verfasst von Teresa Koch und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuromuscular Diseases, Center for Neurology, University Hospital Bonn, Bonn, 53127, Germany. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Troponin T, Biomarkers. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Boris Canessa Foundation, Alzheimer Forschung Initiative e.V, Hertie Network of Excellence in Clinical Neuroscience.
Abstract (Originalsprache)
Objective
Informative biomarkers are an urgent need in the management of amyotrophic lateral sclerosis. Serum cardiac troponin T is elevated in the majority of amyotrophic lateral sclerosis patients and increases with disease progression. We sought to establish the informative value of cardiac troponin T with regard to respiratory function, a major prognostic factor in amyotrophic lateral sclerosis.
Methods
In this retrospective observation, we analyzed two independent hospital‐based cohorts ( d = discovery cohort; v = validation cohort) regarding serum cardiac troponin T ( n d = 298; n v = 49), serum neurofilament light chain ( n d = 117; n v = 17), and respiratory tests ( n d = 93; n v = 49).
Results
Serum cardiac troponin T, in contrast to serum neurofilament levels, was associated with the respiratory domain of the revised amyotrophic lateral sclerosis functional rating scale and with pulmonary function parameters, namely forced vital capacity % ( r = −0.45, p = 0.001) and slow vital capacity % ( r = −0.50, p = 0.001). Serum cardiac troponin T reliably discriminated benchmarks of slow vital capacity
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neuromuscular Diseases, Center for Neurology, University Hospital Bonn, Bonn, 53127, Germany.
- Department for Medical Biometry, Informatics and Epidemiology, University Hospital Bonn, Bonn, 53127, Germany.
- Department of Pulmology, Neukölln Hospital, Berlin, Germany.
- Department of Parkinson, Sleep and Movement Disorders, Center for Neurology, University Hospital Bonn, Bonn, 53127, Germany.
- Institute of Physiology II, University Hospital Bonn, Bonn, 53115, Germany.
- Department of Neurology, Alfried - Krupp-Hospital, Essen, Germany.
ORCID-Profile: Teresa Koch, Sergio Castro-Gomez, Patrick Weydt
Förderung
- Boris Canessa Foundation
- Alzheimer Forschung Initiative e.V
- Hertie Network of Excellence in Clinical Neuroscience
- BONFOR-Forschungskommission der Medizinischen Fakultät Bonn
- Neuro-aCSis Bonn Neuroscience Clinician Scientist Program
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Koch, T., Fabian, R., Weinhold, L., Koch, F. W., Barakat, S., Castro-Gomez, S., Grehl, T., Bernsen, S., & Weydt, P. (2024). Cardiac troponin T as a serum biomarker of respiratory impairment in amyotrophic lateral sclerosis. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.52126
Vancouver
Koch T, Fabian R, Weinhold L, Koch FW, Barakat S, Castro-Gomez S, et al. Cardiac troponin T as a serum biomarker of respiratory impairment in amyotrophic lateral sclerosis. Annals of Clinical and Translational Neurology. 2024. doi:10.1002/acn3.52126
BibTeX
@article{Koch2024,
author = {Koch, Teresa and Fabian, Rachel and Weinhold, Leonie and Koch, Franz-W and Barakat, Saman and Castro-Gomez, Sergio and Grehl, Torsten and Bernsen, Sarah and Weydt, Patrick},
title = {Cardiac troponin T as a serum biomarker of respiratory impairment in amyotrophic lateral sclerosis},
journal = {Annals of Clinical and Translational Neurology},
year = {2024},
doi = {10.1002/acn3.52126}
}
EUVIMED